Search
SOLACI Congress
SOLACI CongressesSOLACI-SOCIME'18

SOLACI-SOCIME’18

solaci
solaci
30
0

Here you will find the most relevant articles about the SOLACI-SOCIME 2018 Congress, held on August 1st, 2nd & 3rd at Expo Santa Fe

If you cannot view the articles, click here.

Previous article
TAVR in Patients with Classical Low Flow, Low Gradient
Next article
Peri-Procedural Infarction: More Frequent than and Not as Innocent as We Thought
solaci
solaci

More articles by this author

SOLACI-SBHCI 23

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-CACI 21

solaci - 0
Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress. If you cannot view the articles, click here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Congresses

SOLACI-SBHCI 23

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.
solaci -
SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

Dr. Carlos Fava - 0
This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Dr. Omar Tupayachi - 0
Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

Dr. Carlos Fava - 0
This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Dr. Omar Tupayachi - 0
Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

Institutional News

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy